Roles of Parathyroid hormone-related protein (PTHrP) in bone metastases and cachexia of malignancy

甲状旁腺激素相关蛋白(PTHrP)在骨转移和恶性肿瘤恶病质中的作用

基本信息

  • 批准号:
    16590917
  • 负责人:
  • 金额:
    $ 2.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2006
  • 项目状态:
    已结题

项目摘要

Parathyroid hormone-related protein (PTHrP) was isolated as a causal protein for humoral hypercalcemia of malignancy (HHM), but PTHrP and its receptor are expressed ubiquitously in almost all organ tissues. PTHrP may effect not only hypercalcemia, but bone metastases, proliferation, and secretion of various cytokines in cancer patients. We undertook investigation of PTHrP in bone metastases and cachexia of malignancy.1) Roles of PTHrP in bone metastases of breast cancer : We used a bone metastasis model of human breast cancer cell line MDA-MB-231 intraventricular injection into nude mice, and isolated highly bone-metastatic subline of MDA-MB-231. Those cells expressed the same level of PTHrP mRNA as parent cells, but expressed higher level of PTHrP mRNA when stimulated with TGF-beta. On the other hand, TGF-beta effects on proliferation of the subline was the same as the parent cells, but BMP-4 stimulated growth of the subline, although it did not stimulated growth of the parent cells. PTHrP-neutralizing antibody did not inhibit the cell proliferation, so PTHrP seemed to have no effect on the proliferation of those cells. PTHrP antibody inhibits formation of bone metastases in nude mice model when it was administrated in the early phase, not in the late phase, so PTHrP seems to have effects on bone metastases in the early phase. We are now investigating effects of new molecular target drugs (EGF receptor inhibitor, SRC inhibitor, etc.) on bone metastases and PTHrP expression.2) Roles of PTHrP in cachexia : We investigated blood cytokine levels of patients with high blood PTHrP levels, and showed they had high levels of blood IL-6, IL-8, and TNF-alpha. These high levels of PTHrP and cytokines correlated with some symptoms of cachexia, such as body weight loss. We are also investigating effect of bisphosphonates on cytokine levels and blood levels of hepcidin, which is considered to be one of causal proteins for anemia of chronic disease.
甲状旁腺素相关蛋白(PTHrP)是一种引起恶性肿瘤体液性高钙血症(HHM)的蛋白质,但PTHrP及其受体在几乎所有器官组织中都广泛表达。PTHrP不仅可以影响高钙血症,还可以影响癌症患者的骨转移、增殖和各种细胞因子的分泌。1)PTHrP在乳腺癌骨转移中的作用:采用人乳腺癌细胞株MDA-MB-231裸鼠脑室内注射建立骨转移模型,分离出高骨转移的MDA-MB-231亚株。这些细胞表达与亲本细胞相同水平的PTHrP mRNA,但在TGF-β刺激时表达更高水平的PTHrP mRNA。另一方面,TGF-β对亚系增殖的影响与亲本细胞相同,但BMP-4刺激亚系的生长,尽管它不刺激亲本细胞的生长。PTHrP中和抗体不抑制细胞增殖,因此PTHrP似乎对这些细胞的增殖没有影响。PTHrP抗体在裸鼠骨转移模型中早期给药抑制骨转移的形成,而在晚期不抑制骨转移,因此PTHrP似乎在早期对骨转移有作用。我们正在研究新的分子靶向药物(EGF受体抑制剂,SRC抑制剂等)的作用。2)PTHrP在恶病质中的作用:我们研究了具有高血液PTHrP水平的患者的血液细胞因子水平,并且显示他们具有高水平的血液IL-6、IL-8和TNF-α。这些高水平的PTHrP和细胞因子与恶病质的一些症状相关,如体重减轻。我们也在研究双膦酸盐对细胞因子水平和hepcidin血液水平的影响,hepcidin被认为是慢性疾病贫血的致病蛋白之一。

项目成果

期刊论文数量(30)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Efficacy and safety of trastuzumab as a single agent in heavily pretreated patients with HER-2/NEU-overexpressing metastatic breast cancer
  • DOI:
    10.1177/030089160409000110
  • 发表时间:
    2004-01-01
  • 期刊:
  • 影响因子:
    1.9
  • 作者:
    Sawaki, M;Ito, Y;Hatake, K
  • 通讯作者:
    Hatake, K
Blockade of bulky lymphoma-associated CD55 expression by RNA interference overcomes resistance to complement-dependent cytotoxicity with rituximab
  • DOI:
    10.1111/j.1349-7006.2006.00139.x
  • 发表时间:
    2006-01-01
  • 期刊:
  • 影响因子:
    5.7
  • 作者:
    Terui, Y;Sakurai, T;Hatake, K
  • 通讯作者:
    Hatake, K
Tolerability and safety of classic cyclophosphamide, methotrexate, and fluorouracil treatment in Japanese patients with early breast cancer.
日本早期乳腺癌患者经典环磷酰胺、甲氨蝶呤和氟尿嘧啶治疗的耐受性和安全性。
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Tada K;et al.
  • 通讯作者:
    et al.
Gene therapy for breast cancer. --Review of clinical gene therapy trials for breast cancer and MDR1 gene therapy trial in Cancer Institute Hospital. (Review)
乳腺癌的基因治疗。
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Takahashi S;et al.
  • 通讯作者:
    et al.
High prevalence of HER-2/neu and p53 overexpression in inflammatory breast cancer.
  • DOI:
    10.2325/jbcs.13.172
  • 发表时间:
    2006-01-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sawaki, Masataka;Ito, Yoshinori;Hatake, Kiyohiko
  • 通讯作者:
    Hatake, Kiyohiko
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TAKAHASHI Shunji其他文献

TAKAHASHI Shunji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TAKAHASHI Shunji', 18)}}的其他基金

Novel strategy to awake gene cluster using small molecules that activate LAL family transcriptional regulator
使用激活 LAL 家族转录调节因子的小分子唤醒基因簇的新策略
  • 批准号:
    24658088
  • 财政年份:
    2012
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Elucidation of reaction mechanism of novel biosynthetic enzymes for derivatization of reveromycin
阐明新型生物合成酶用于瑞维霉素衍生化的反应机制
  • 批准号:
    21580104
  • 财政年份:
    2009
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetic engineering of reveromycin A biosynthetic gene cluster and creation of its derivatives
瑞维霉素A生物合成基因簇的基因工程及其衍生物的创建
  • 批准号:
    18580085
  • 财政年份:
    2006
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Bone morphognetic proteins (BMPs) and BMP receptor expression in breast cancer cells and their significance in bone metastases
乳腺癌细胞中骨形态发生蛋白(BMP)和BMP受体的表达及其在骨转移中的意义
  • 批准号:
    10671050
  • 财政年份:
    1998
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Vitamin D and beta-amyloid signaling in hyperparathyroidism
甲状旁腺功能亢进症中的维生素 D 和 β-淀粉样蛋白信号传导
  • 批准号:
    10668177
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Next Gen Targeted nanoparticles for Inhibiting Gli2 in Bone Metastatic Tumors
用于抑制骨转移肿瘤中 Gli2 的下一代靶向纳米颗粒
  • 批准号:
    10623705
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Characterizing neurocognitive symptoms in older adults with primary hyperparathyroidism
原发性甲状旁腺功能亢进症老年人的神经认知症状特征
  • 批准号:
    10725231
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Comparative Safety and Efficacy of Low-dose Vitamin D in Kidney Failure
小剂量维生素 D 治疗肾衰竭的安全性和疗效比较
  • 批准号:
    10721791
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Exposing the role of MYC in small cell carcinoma of the ovary hypercalcemic type
揭示 MYC 在卵巢高钙血症型小细胞癌中的作用
  • 批准号:
    10728702
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Tissue-Specific Regulation and Effects of CYP24A1
CYP24A1 的组织特异性调控和作用
  • 批准号:
    10580931
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Developmental Infant Effects of Exposure to High Doses of Oral Insulin in Human Milk (HM)
接触高剂量口服母乳胰岛素 (HM) 对婴儿发育的影响
  • 批准号:
    10557142
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
Repurposing rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations of CYP24A1
重新利用利福平可降低 CYP24A1 失活突变患者的血钙和尿钙水平升高
  • 批准号:
    10581278
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
Identification of selective inhibitors of PTH-receptor for Jansen’s metaphyseal chondrodysplasia
Jansen 干骺端软骨发育不良的 PTH 受体选择性抑制剂的鉴定
  • 批准号:
    10575154
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
Tracing and targeting the epigenetic heterogeneity in breast cancer metastasis
追踪和靶向乳腺癌转移中的表观遗传异质性
  • 批准号:
    10672517
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了